Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape.
Subscribe now and be part of the conversation that's shaping the future of biotechnology.
Get ready for an immersive experience into the world of biotech with The BioHub.
The BioHub hosts Johanna Kaufman, Chief Scientific Officer at DeckBio, for a 28-minute conversation about her career trajectory and current work in oncology and immunology. Kaufman has worked across multiple segments of the biotech and pharma landscape, including roles at Genocea, TESARO, GSK, and Codagenix, where she…
Worth it if you're interested in biotech career paths, the evolution of oncology drug development strategy, or want to hear from someone with experience across multiple major companies in the space.
The BioHub hosts Dr. Sam Blackman, a physician-scientist with a dual career spanning clinical medicine and biotechnology entrepreneurship. Blackman's background includes training as a physician with early specialization in pediatric oncology, giving him deep clinical insight into unmet medical needs in cancer care.…
Worth it if you're interested in the biotech industry, pediatric cancer drug development, or the career path from clinical medicine to entrepreneurship and investing.
The BioHub Episode 241 features Howard Berman (CEO) and Kia Motesharei (President/COO) of ReAlta Life Sciences, a clinical-stage biotechnology company. The episode positions itself as an exploration of biotech leadership and value creation, with both guests bringing extensive backgrounds in biotechnology, capital…
Worth it if you're deeply invested in ReAlta Life Sciences specifically or seeking general biotech leadership perspectives, but not if you want concrete clinical updates or strategic breakthroughs.
The BioHub Podcast hosts Dr. Inder Kaul, Chief Medical Officer at Draig Therapeutics, for a 27-minute conversation on neuropsychiatric drug development. Kaul brings substantial credentials: he played a key role in developing Cobenfy at Karuna Therapeutics and Bristol Myers Squibb, described as one of the most…
Worth it if you follow CNS drug development, are curious about psychiatric medicine innovation, or want insider perspective on translating novel neuroscience mechanisms into approved therapies.
